Stock SANA SANA BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Sana Biotechnology, Inc.

Equities

SANA

US7995661045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
8.58 USD +5.99% Intraday chart for Sana Biotechnology, Inc. +3.87% +110.29%
Apr. 18 Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development CI
Apr. 09 Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024. CI

Evolution of the average Target Price on Sana Biotechnology, Inc.

Price target over the last 5 years

History of analyst recommendation changes

bd1675ace3b6.KzVRR_iMKbcM-48czkA4g9fczg0cQImGJry0-q1oXKs.GFg6AYK9EIJDmOp3vg1Wz6WJvE9ddLvFZc_nw8s-H_4cUyt3kb9P-3jDzg~3d4d1ad8f6e5a078be3d35377791639b

Analyst Recommendations on Sana Biotechnology, Inc.

JMP Securities Adjusts Sana Biotechnology Price Target to $15 From $8, Maintains Market Outperform Rating MT
HC Wainwright Upgrades Sana Biotechnology to Buy From Neutral, Price Target is $12 MT
JMP Securities Trims Price Target on Sana Biotechnology to $8 From $9, Maintains Market Outperform Rating MT
JMP Securities Initiates Sana Biotechnology With Market Outperform Rating, Price Target is $9 MT
Citigroup Starts Sana Biotechnology at Buy With $8 Price Target MT
TD Cowen Initiates Sana Biotechnology at Market Perform MT
HC Wainwright Starts Sana Biotechnology at Neutral MT
Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data RE
Morgan Stanley Adjusts Price Target on Sana Biotechnology to $13 From $15, Maintains Overweight Rating MT
Morgan Stanley Lowers Sana Biotechnology's Price Target to $15 From $17, Maintains Overweight Rating MT
Morgan Stanley Adjusts Sana Biotechnology's Price Target to $17 from $40, Keeps Overweight Rating MT
SANA BIOTECHNOLOGY : JPMorgan Adjusts Price Target for Sana Biotechnology to $31 From $35, Maintains Neutral Rating MT
SANA BIOTECHNOLOGY : Goldman Sachs Adjusts Price Target on Sana Biotechnology to $34 From $39, Maintains Neutral Rating MT
SANA BIOTECHNOLOGY : JPMorgan Starts Sana Biotechnology at Neutral With $35 Price Target MT
SANA BIOTECHNOLOGY : Morgan Stanley Starts Sana Biotechnology at Overweight With $40 Price Target MT
SANA BIOTECHNOLOGY : Goldman Sachs Starts Sana Biotechnology at Neutral With $40 Price Target MT
SANA BIOTECHNOLOGY : BofA Securities Starts Sana Biotechnology at Buy With $45 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
8.58 USD
Average target price
11.17 USD
Spread / Average Target
+30.15%
High Price Target
15 USD
Spread / Highest target
+74.83%
Low Price Target
5 USD
Spread / Lowest Target
-41.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sana Biotechnology, Inc.

JMP Securities
HC Wainwright
Citigroup
TD Cowen
Morgan Stanley
Goldman Sachs
JPMorgan Chase
BofA Securities
J.P. Morgan Chase

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SANA Stock
  4. Consensus Sana Biotechnology, Inc.